Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

266
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
266
Liver Physiology01:30

Liver Physiology

4.5K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
4.5K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

370
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
370
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

24
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
24
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

340
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
340
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

20
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
20

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic and therapeutic guidelines for pancreatic cystic tumors: recommendations of Polish Pancreatic Club experts.

Przeglad gastroenterologiczny·2025
Same author

Mitochondrial Dysfunction and Reduced TCA Cycle Metabolite Levels in Inflammatory Bowel Disease Patients.

Journal of inflammation research·2025
Same author

Pancreatitis in Pregnancy-Comprehensive Review.

International journal of environmental research and public health·2022
Same author

Gullo's syndrome - what do we know?

Przeglad gastroenterologiczny·2021
Same author

The influence of erythropoietin on apoptosis and fibrosis in the early phase of chronic pancreatitis in rats.

Archives of medical science : AMS·2021
Same author

Serum miR-210-3p can be used to differentiate between patients with pancreatic ductal adenocarcinoma and chronic pancreatitis.

Biomedical reports·2020

Related Experiment Video

Updated: Apr 21, 2026

Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model
06:45

Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model

Published on: January 19, 2024

1.5K

Liver function disorders in pregnancy: physiology or pathology?

Wiktoria Sielwanowska-Lasek1, Agnieszka Mądro2

  • 1Doctoral School, Medical University of Lublin, Lublin, Poland.

Przeglad Gastroenterologiczny
|April 20, 2026
PubMed
Summary

Interpreting abnormal liver function tests in pregnancy requires careful consideration of physiological changes versus pathological conditions. Early diagnosis and management of pregnancy-related liver diseases are crucial for maternal and fetal well-being.

Keywords:
HELLP syndromecholestasisliver diseasespregnancy

More Related Videos

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

5.6K
An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.9K

Related Experiment Videos

Last Updated: Apr 21, 2026

Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model
06:45

Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model

Published on: January 19, 2024

1.5K
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

5.6K
An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.9K

Area of Science:

  • Hepatology
  • Obstetrics
  • Biochemistry

Background:

  • Physiological liver function changes in pregnancy can mimic liver disease.
  • Accurate interpretation of liver markers is essential for maternal and fetal health.
  • Differentiating normal changes from pathology presents a diagnostic challenge.

Purpose of the Study:

  • To review liver diseases specific to pregnancy.
  • To discuss liver conditions independent of pregnancy that may affect pregnant individuals.
  • To highlight diagnostic challenges and management strategies for liver diseases during pregnancy.

Main Methods:

  • Literature review of pregnancy-specific liver diseases.
  • Discussion of non-pregnancy-related liver conditions in gestation.
  • Emphasis on clinical presentation, pregnancy stage, and diagnostic criteria.
  • Inclusion of differential diagnoses such as drug-induced liver injury and viral infections.

Main Results:

  • Pregnancy-specific liver diseases include hyperemesis gravidarum, HELLP syndrome, preeclampsia/eclampsia, intrahepatic cholestasis, and acute fatty liver disease.
  • Independent liver diseases like autoimmune hepatitis (AIH), primary biliary cirrhosis, and primary sclerosing cholangitis require specific management.
  • AIH may require adjusted immunosuppression during the perinatal period.

Conclusions:

  • Distinguishing physiological liver changes from disease is critical.
  • A thorough medical history and symptom analysis are vital for accurate diagnosis.
  • Prompt diagnosis and treatment of liver diseases in pregnancy minimize complication risks.